First Treatment for Breast Cancer with certain Inherited Gene Mutation
<p>The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Scientific Journal of Genetics and Gene Therapy - Peertechz Publications,
2018-02-15.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer.</p> |
|---|---|
| DOI: | 10.17352/sjggt.000013 |